Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Permanyer
2022-07-01
|
| シリーズ: | Gaceta Mexicana de Oncología |
| 主題: | |
| オンライン･アクセス: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|